Alergologia Polska - Polish Journal of Allergology

Assessment of the course of vaccinations in patients with positive skin tests for the anti-COVID-19 vaccine

Agata Sztramska 1
,
Julia Glińska 1
,
Kaja Kozielec 1
,
Maja Kozielec 1
,
Michał Marek Nizar 1
,
Jerzy Kruszewski 2
,
Andrzej Bant 2
,
Jan Romantowski 1
,
Marek Niedoszytko 1

  1. Department of Allergology, Medical University of Gdansk, Poland

  2. Department of Internal Medicine, Infectious Diseases and Allergology, Military Institute of Medicine – National Research Institute, Warsaw, Poland

Alergologia Polska – Polish Journal of Allergology

DOI: https://doi.org/10.5114/pja.2026.164681
Data publikacji online: 2026/09/22
Article file
PJA Assessment of the course.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. McCreary EK, Pogue JM. Coronavirus disease 2019 treatment: a review of early and emerging options. Open Forum Infect Dis 2020; 7: ofaa105.
  2. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020; 383: 2603-15.
  3. Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 2021; 384: 403-16.
  4. Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021; 397: 99-111.
  5. Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med 2021; 384: 2187-201.
  6. Smout A. UK Issues Anaphylaxis Warning on Pfizer Vaccine after Adverse Reactions. Reuters; 2020. https://www.reuters.com/article/health‐coronavirus‐britain‐vaccine‐idUSKBN28J1D1. n.d.
  7. Peters MDJ. Addressing vaccine hesitancy and resistance for COVID-19 vaccines. Int J Nurs Stud 2022; 131: 104241.
  8. Baghani M, Fathalizade F, Loghman AH, et al. COVID-19 vaccine hesitancy worldwide and its associated factors: a systematic review and meta-analysis. Sci One Health 2023; 2: 100048.
  9. Banerji A, Wickner PG, Saff R, et al. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach. J Allergy Clin Immunol Pract 2021; 9: 1423-37.
  10. Greenhawt M, Abrams EM, Shaker M, et al. The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach. J Allergy Clin Immunol Pract 2021; 9: 3546-67.
  11. Kricorian K, Civen R, Equils O. COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety. Hum Vaccin Immunother 2022; 18: 1950504.
  12. CDC COVID‐19 Response Team. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer‐BioNTech COVID‐19 vaccine‐ United States, December 14‐23. MMWR Morb Mortal Wkly Rep. 2021; 70: 46-51.
  13. Johnston MS, Galan A, Watsky KL, Little AJ. Delayed localized hypersensitivity reactions to the Moderna COVID-19 Vaccine. JAMA Dermatol 2021; 157: 716.
  14. Sellaturay P, Nasser S, Islam S, et al. Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID‐19 vaccine. Clin Exp Allergy 2021; 51: 861-3.
  15. Stehlin F, Khoudja RY, Al-Otaibi I, et al. COVID-19 booster vaccine acceptance following allergy evaluation in individuals with allergies. J Allergy Clin Immunol Pract 2024; 12: 242-5.e2.
  16. Lazarus JV, Wyka K, White TM, et al. A survey of COVID-19 vaccine acceptance across 23 countries in 2022. Nat Med 2023; 29: 366-75.
  17. Romantowski J, Kruszewski J, Solarski O, et al. Protocol of safe vaccination against COVID‐19 in patients with high risk of allergic reactions. Clin Transl Allergy 2022; 12: e12152.
  18. AlMuhizi F, Ton-Leclerc S, Fein M, et al. Successful desensitization to mRNA COVID-19 vaccine in a case series of patients with a history of anaphylaxis to the first vaccine dose. Front Allergy 2022; 3: 825164.
  19. AlOtaibi I, Almuhizi F, Ton-Leclerc S, et al. Anaphylaxis induced by mRNA COVID-19 vaccines: follow-up and booster dose after previous desensitization. Front Allergy 2023; 4: 1056619.
  20. Blumenthal KG, Li Y, Acker WW, et al. Multiple drug intolerance syndrome and multiple drug allergy syndrome: epidemiology and associations with anxiety and depression. Allergy 2018; 73: 2012-23.
  21. Nilsson L, Brockow K, Alm J, et al. Vaccination and allergy: EAACI position paper, practical aspects. Pediatr Allergy Immunol 2017; 28: 628-40.
  22. COVID Transition Initiative n.d. https://www.covid-transition.com/ (accessed May 10, 2025).
  23. Lazarus JV, White TM, Wyka K, et al. Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023. Nat Med 2024; 30: 1559-63.
  24. WHO Director-General’s opening remarks at the media briefing – 5 May 2023 n.d. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing---5-may-2023 (accessed May 10, 2025).
Copyright: © Polish Society of Allergology This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Coverage in
Integrated with
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications